newsfilter
← Latest News
GlobeNewswire·

Psyence Taps Another Pharma Exec to Drive its Clinical Program

TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG, OTCQB:PSYGF) ("Psyence" or the "Company"), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce